Summary
Hyperbilirubinaemia remains one of the most common and more important pathological conditions in the newborn. The possibility that the so-called physiological or developmental hyperbilirubinaemia, with relatively low levels of serum bilirubin, could be responsible for bilirubin encephalopathy in the small premature infant is of great concern to the neonatologist; premature newborns are prone to developing hyperbilirubinaemia.
Current methodologies for suppressing severe neonatal jaundice include: (a) attempts to stimulate liver conjugating enzymes using drugs such as phenobarbital; (b) attempts to degrade bilirubin with phototherapy; and (c) exchange transfusion.
It is too soon to consider tin-protoporphyrin as a drug for the prevention and treatment of neonatal hyperbilirubinaemia. However, if it can be shown that tin-protoporphyrin can serve as a safe and less costly alternate treatment, a considerable improvement in the management of neonatal jaundice would be achieved.
Similar content being viewed by others
References
Ahdab-Barmada M, Moosy J. The neuropathology of kernicterus in the premature neonate: diagnostic problems. Journal of Neuropathology and Experimental Neurology 43: 45–55, 1984
Batton DG, Mailes MJ, Schulman G. Serum potassium changes following packed red cell transfusions in newborn infants. Transfusions 23: 163, 1983
Blackburn MG, Orzalesi MM, Pigram P. The combined effect of phototherapy and phenobarbital on serum bilirubin levels of premature infants. Pediatrics 49: 110–116, 1972
Blanchette VS, Gray E, Hardie MJ, et al. Hyperkaliemia after neonatal exchange transfusion: risk eliminated by washing red cell concentrates. Journal of Pediatrics 105: 321–324, 1984
Brann BS, Stonestreet BS, Oh W, et al. The in vivo effect of bilirubin and sulfisoxazole on cerebral oxygen, glucose and lactate metabolism in newborn piglets. Pediatric Research 22: 135–141, 1987
Bratlid D. Bilirubin binding by human erythrocytes. Scandinavian Journal of Clinical and Laboratory Investigation 21: 91–97, 1972
Brodersen R. Binding of bilirubin to albumin. Critical Reviews of Clinical and Laboratory Sciences 11: 305–399, 1979a
Brodersen R. Bilirubin: solubility and interaction with albumin and phospholipid. Journal of Biological Chemistry 254: 2364–2369, 1979b
Brodersen R. Bilirubin transport in the newborn infant, reviewed with relation to kernicterus. Journal of Pediatric 96: 349–356, 1980
Brown AK, Kim MH, Wu PYK, Bryla DA. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia. Pediatrics (Suppl. 75): 393–400, 1985
Burgess GH, Oh W, Bratlid D, et al. The effects of brain blood flow on brain bilirubin deposition in newborn piglets. Pediatric Research 19: 691–696, 1985
Callahan EW, Thaler MM, et al. Phototherapy of severe unconjugated hyperbilirubinemia: formation and removal of labeled bilirubin derivatives. Pediatrics 346: 841–848, 1970
Cao A, Falorni A, Francassini F, et al. Phenobarbital effect on serum bilirubin levels in underweight infants. Helvetica Pediatrica Acta 28: 231–238, 1973
Carreddu P, Marini A. Stimulating bilirubin conjugation. Lancet 1: 982–983, 1968
Careddu P, Piceni-Sereni L, Giunta A, et al. Sulla possibilità di attivare i processi di coniugazione e di escrezione epatica della bilirubina mediante alcuni farmaci: ricerche sperimentali con la dietilamide dell’acido nicotinico (Coramina) e l’acido feniletil barbiturico (Gardenale). Minerva Pediatrica 55: 1559, 1964
Cashore WJ, Oh W. Free bilirubin concentration and bilirubin-binding affinity in term and preterm infants. Journal of Pediatrics 96: 521–527, 1980
Cashore WJ, Oh W. Unbound bilirubin and kernicterus in low birth weight infants. Pediatrics 69: 481–485, 1982
Chan G, Schiff D. Variance in albumin loading in exchange transfusions. Journal of Pediatrics 88: 609–613, 1976
Claireaux AE, Cole PG, Lathe GH. Icterus of the brain in the newborn. Lancet 2: 1226–1230, 1953
Clark CF, Torii S, Hamamoto, Kaito H. The bronze baby syndrome: post-mortem data. Journal of Pediatrics 88: 461–464, 1976
Cornelius CE, Rogbers PA. Prevention of neonatal hyperbilirubinemia in rhesus monkeys by tin-protoporphyrin. Pediatric Research 18: 728–730, 1984
Cremer, Periman, Richards. Influence of light on the hyperbilirubinaemia of infants. Lancet 1(7030): 1094–1097, 1958
Curtis-Cohen M, Stahl GE, Costarino AT, Polin RA. Randomized trial of prophylactic phototherapy in the infant with very low birth weight. Journal of Pediatrics 107: 121–124, 1985
Diamond I, Schmid R. Neonatal hyperbilirubinemia and kernicterus: experimental support for treatment by exposure to visible light. Archives of Neurology 18: 699, 1968
DiToro R, Lupi L, Ansanelli V. Glucuronidation of the liver in premature babies. Nature 219: 265, 1968
Donzelli GP, Vecchi C. Piu luce sulla fototerapia. Pediatrica 3: 55, 1985
Gartner LM, Snyder RN, Chabon RS, Bernstein J. Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics 45: 906–917, 1970
Granati G, Largajolli, Rubaltelli FF, et al. Efficacy and safety of the ‘integral’ phototherapy for neonatal hyperbilirubinemia. Clinical Pediatrics 23: 483–486, 1984
Hammerman C, Eidelman A, Lee KS, Gartner LM. Comparative measurements of phototherapy: a practical guide. Pediatrics 67: 368–372, 1981
Karp WB. Biochemical alterations in neonatal hyperbilirubinemia and bilirubin encephalopathy: a review. Pediatrics 64: 361–368, 1979
Kappas a, Drummond GS, Manola T, et al. The use of Sn-Protoporphyrin in the management of hyperbilirubinemia in newborn infants with direct Coombs positive ABO-incompatability. Pediatrics 81: 485–497, 1988
Karplus N, Lee C, Cashore WJ, Oh W. The effect of brain bilirubin deposition on auditory brain stem evoked responses in rats. Early Human Development 16: 185–194, 1988
Keenan WJ, Novak KK, Sutherland JM, et al. Morbidity and mortality associated with exchange transfusion. Pediatrics Supplement 75: 417–421, 1985
Lee C, Oh W, Stonestreet BS, et al. Permeability of the blood-brain-barrier for 125I-albumin-bound bilirubin in newborn piglets. Pediatric Research 25: 452–456, 1989
Leonard M, Noy N, Zakim D. The interactions of bilirubin with model and biological membranes. Journal of of Biological Chemistry 264: 5648–5652, 1989
Lie SO, Bratlid D. The protective effect of albumin on bilirubin toxicity in human fibroblasts. Scandinavian Journal of Clinical Investigation 26: 37–41, 1970
Mailes MJ, Li TK, Piechocki JT, Werthman WW. The effect of exchange transfusion on serum ionized calcium. Pediatrics 53: 683–686, 1974
Mancini GF, D’Elia R, Rubaltelli FF. L’exsanguinotrasfusione in neonatologia: nuove esperienze e nuove indicazioni. La Pediatria Medica e Chirurgica 2: 587–590, 1980
Mayor Jr F, Diez-Guerra J, Valdivieso F, et al. Effect of bilirubin on the membrane potential of rat synaptosomes. Journal of Neurochemistry 47: 363–369, 1986
McDonagh AF, Lightner DA. ‘Like a shrivelled blood orange’: bilirubin, jaundice and phototherapy. Pediatrics 75: 443–455, 1985
McDonagh AF, Palma LA. Hepatic excretion of circulating bilirubin photoproducts in the Gunn rat. Journal of Clinical Investigation 66: 1182–1185, 1980
Messner KH. Light toxicity to newborn retina. Abstract. Pediatric Research 12: 530, 1978
Messner KH, Maiseis MJ, Leure Du Pree AE. Phototoxicity to the newborn primate retina. Investigative Ophthalmology and Visual Sciences 17: 178, 1978
Mollison PL, Cutbush M. Haemolytic disease in the newborn. In Gairdner D (Ed.) Recent advances in pediatrics, p. 110, Blakiston, New York, 1954
Murao S, Tanaka N. A new enzyme ‘bilirubin oxidase’ produced by Myrothecium Verrucarea MT-1. Agricultural Biological Chemistry 45: 2383, 1981
Nakamura H, Takada S, Shimabaku R, et al. Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics 75: 703–708, 1985
Nicolopoulos D, Hadjigeorgiou E, Malamitsi A, et al. Combined treatment of neonatal jaundice with cholestyramine and phototherapy. Journal of Pediatrics 93: 684–688, 1978
Nicolopoulos D, Hadjigeorgiou E, Malamitsi-Puchner A, et al. Reducing the duration of phototherapy for neonatal jaundice by cholestyramine administration. In Rubaltelli et al. (Eds) Neonatal jaundice: new trends in phototherapy, pp. 257–263, Plenum Press, New York, 1984
Odell GB, Cutcher GR, Whitington PF, Yang G. Enterai administration of agar as an effective adjunct to phototherapy of neonatal hyperbilirubinemia. Pediatric Research 17: 810–814, 1983
Onishi S, Itoh S, Isobe K, et al. Mechanism of development of bronze baby syndrome in neonates treated with phototherapy. Pediatrics 69: 273–276, 1982
Orzalesi M, Savignon PG, Nodari S, et al. The effect of agar feeding on serum bilirubin levels of low birthweight infants. Abstract 675. Pediatric Research 9: 369, 1975
Pearlman MA, Gartner LM, Lee K, et al. Absence of kernicterus in low birth weight infants from 1971 through 1976: comparison with findings in 1966 and 1967. Pediatrics 62: 460–464, 1978
Poland RL, Odell GB. Physiologic jaundice: the enteropathic circulation of bilirubin. New England Journal of Medicine 284: 1, 1971
Romagnoli C, Polidori G, Foschini M, et al. Agar in the management of hyperbilirubinemia in the premature baby. Archives of Diseases of Childhood 50: 202–204, 1975
Rubaltelli FF, Granati B. Phototherapy of neonatal hyperbilirubinemia. Medicine, Biology, and Environment 8: 185, 1980
Rubaltelli FF, Granati B, Fortunato A, et al. Inhibitory effects of bilirubin and photobilirubin on neonatal and adult T-lymphocytes and granulocytes. Biology of the Neonate 42: 152–158, 1982
Rubaltelli FF, Granati G, Mancini GF, et al. La fototerapia nel trattamento della mallatia emolitica del neonato da incompatibilità Rh e ABO. Rivista Italiana di Pediatria 4: 337–343, 1978a
Rubaltelli FF, Guerrini P, Reddi E, Jori G. Tin-protoporphyrin in the management of children with Crigler-Najjar Disease. Pediatrics 84: 728–731, 1989
Rubaltelli FF, Jori G, Reddi E. Bronze baby syndrome: a new porphyrin-related disorder. Pediatric Research 17: 327–330, 1983
Rubaltelli FF, Largajolli G. Effect of light exposure on gut transit time in jaundiced newborns. Acta Paediatrica Scandinavica 62: 146–148, 1973
Rubaltelli FF, Zanardo V, Granati B. Effect of various phototherapy regimens on bilirubin decrement. Pediatrics 61: 838–841, 1978b
Rubin RA, Balow B, Fisch RD. Neonatal serum bilirubin levels related to cognitive development at ages 4 through 7 years. Abstract. Journal of Pediatrics 94: 601, 1979
Santella RG, Rosenkranz HS, Speck WT. Intracellular deoxyribonucleic acid-modifying activity of intermittent phototherapy. Journal of Pediatrics 93: 106–109, 1978
Scalon JW, Krakaur R. Hyperkalemia following exchange transfusion. Journal of Pediatrics 96: 108–110, 1980
Speck WT. Effect of phototherapy on fertilization and embryonic development. Abstract. Pediatric Research 13: 506, 1979
Stern L. Bilirubin metabolism in the newborn: its mechanisms and relationship to kernicterus. In Rubaltelli FF & Jori G (Eds) Neonatal jaundice, pp. 1–12, Plenum Press, New York, 1984
Stern L, Denton RL. Kernicterus in small premature infants. Pediatrics 35: 483–485, 1965
Tan KL. The pattern of bilirubin response to phototherapy for neonatal hyperbilirubinemia. Pediatric Research 16: 670–674, 1982
Teuhunen R, Marver HS, Schmid R. Microsomal hemeoxygenase: characterization of the enzyme. Journal of Biological Chemistry 244: 6388, 1969
Thompson S, Inwood MJ, Ferries P, Baker N. Hyperkaliemia in the neonate: a method to provide acceptable donor blood for exchange transfusion. Canadian Journal of Medical Technology 44: 31, 1982
Trölle D. Phenobarbitone and neonatal icterus. Lancet 1: 251–252, 1968
Ulstrom RA, Eisenblam E. The enterohepatic shunting of bilirubin in the newborn infant: I. use of oral activated charcoal to reduce normal serum bilirubin values. Journal of Pediatrics 65: 27–37, 1964
Vaisman SL, Gartner LM. Pharmacologie treatment of neonatal hyperbilirubinemia. Clinics in Perinatology 2: 37, 1975
Van de Bor M, Van Zeben-Van der Aa TM, Verloove-Vanhorick SP, Brand R, Ruys JH. Hyperbilirubinemia in preteram infants and neurodevelopmental outcome at 2 years of age: results of a National Collaborative Survey. Pediatrics 83: 915–920, 1989
Vasquez J, Garcia-Calvo M, Valdivieso F, et al. Interaction of bilirubin with the synaptosomal plasma membrane. Journal of Biological Chemistry 263: 1255–1265, 1988
Vogl T. Phototherapy of neonatal hyperbilirubinemia bilirubin in unexposed areas of the skin. Journal of Pediatrics 85: 707–710, 1974
Vohr BR, Lester B, Rapisardi G, et al. Abnormal brainstem function correlates with acoustic cry features in term infants with hyeprbilirubinemia. Journal of Pediatrics 115: 303–308, 1989a
Vohr BR, Rapisardi G, Karp D, et al. Behavioral changes correlated with cry characteristics and brainstem auditory evoked responses (BAER) in term infants with moderate hyperbilirubinemia. Abstract. Pediatric Research 25: 19A, 1989b
Wennberg RP, Ahlfors CE, Bickers R, et al. Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: improvement with exchange transfusion. Journal of Pediatrics 100: 624–626, 1982
Wennberg RP, Hance AJ. Experimental bilirubin encephalopathy: importance of total bilirubin, protein binding, and blood-brain-barrier. Pediatric Research 20: 789–792, 1986
Wieland P, Duc G, Binswanger V, Fisher JA. Parathyroid hormone response in newborn infants during exchange transfusion with blood supplemented with citrate and phosphate: effects of IV calcium. Pediatric Research 13: 963–968, 1979
Yllpo A. Icterus neonatorum (incl. I.n. gravis) und gallenfarb-stoffsekretion bein foetus und neugeboren. Zeitschrift für Kinderheilkunde 9: 208, 1913
Zuelzer WW, Cohen I. ABO hemolytic disease and heterospecific pregnancy. Pediatric Clinics of North America 4: 405–428, 1957
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rubaltelli, F.F., Griffith, P.F. Management of Neonatal Hyperbilirubinaemia and Prevention of Kernicterus. Drugs 43, 864–872 (1992). https://doi.org/10.2165/00003495-199243060-00006
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-199243060-00006